Abstract
γ-secretase is an intramembranous protein complex that cleaves many type-I membrane proteins, including the Notch receptor and the β-amyloid precursor protein (APP). Interest in γ-secretase comes, in part, from the fact that this multiprotein complex is responsible for the cleavage of APP that generates the amyloid-β peptide (Aβ), one of the primary components of amyloid plaques in Alzheimers disease (AD). Over the last years, molecular identification of the complex has shown that γ-secretase is an aspartyl protease composed of four different members that are essential for the enzymatic activity: presenilin 1, aph1, pen-2 and nicastrin. In recent years, an increasing number of type-I membrane proteins have been shown to be cleaved by γ-secretase. How the enzyme cleaves such a set of substrates with diverse functions and subcellular localizations is not well understood. In overexpression assays, the γ-secretase cleavage of some substrates releases intracellular domains with signaling properties. On the other hand, the loose specificity required for intramembrane cleavage has raised the possibility of γ-secretase as the membrane proteasome. The impact of γ-secretase on other substrates has clear implications for the development of new therapies for AD, and in particular for the search of γ-secretase inhibitors or modulators. Interference with the cleavage of some of the γ-secretase substrates has been shown to be associated with serious adverse effects in animal models. The understanding of the mechanism by which γ-secretase recognizes and cleaves all these proteins is of great importance to clarify the function of γ-secretase and its role as a therapeutic target in AD, and possibly in other diseases in which γ- secretase is involved.
Keywords: Notch receptor, γ-secretase substrates, modulators, amyloidβ, Alzheimer's
Current Topics in Medicinal Chemistry
Title: Activity of γ -Secretase on Substrates Other than APP
Volume: 8 Issue: 1
Author(s): Alberto Lleo M. D.
Affiliation:
Keywords: Notch receptor, γ-secretase substrates, modulators, amyloidβ, Alzheimer's
Abstract: γ-secretase is an intramembranous protein complex that cleaves many type-I membrane proteins, including the Notch receptor and the β-amyloid precursor protein (APP). Interest in γ-secretase comes, in part, from the fact that this multiprotein complex is responsible for the cleavage of APP that generates the amyloid-β peptide (Aβ), one of the primary components of amyloid plaques in Alzheimers disease (AD). Over the last years, molecular identification of the complex has shown that γ-secretase is an aspartyl protease composed of four different members that are essential for the enzymatic activity: presenilin 1, aph1, pen-2 and nicastrin. In recent years, an increasing number of type-I membrane proteins have been shown to be cleaved by γ-secretase. How the enzyme cleaves such a set of substrates with diverse functions and subcellular localizations is not well understood. In overexpression assays, the γ-secretase cleavage of some substrates releases intracellular domains with signaling properties. On the other hand, the loose specificity required for intramembrane cleavage has raised the possibility of γ-secretase as the membrane proteasome. The impact of γ-secretase on other substrates has clear implications for the development of new therapies for AD, and in particular for the search of γ-secretase inhibitors or modulators. Interference with the cleavage of some of the γ-secretase substrates has been shown to be associated with serious adverse effects in animal models. The understanding of the mechanism by which γ-secretase recognizes and cleaves all these proteins is of great importance to clarify the function of γ-secretase and its role as a therapeutic target in AD, and possibly in other diseases in which γ- secretase is involved.
Export Options
About this article
Cite this article as:
D. Lleo M. Alberto, Activity of γ -Secretase on Substrates Other than APP, Current Topics in Medicinal Chemistry 2008; 8 (1) . https://dx.doi.org/10.2174/156802608783334060
DOI https://dx.doi.org/10.2174/156802608783334060 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacodynamic Studies of Chinese Medicine at Levels of Whole Animal, Cell and Molecular Models
Current Medicinal Chemistry Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness
Current Alzheimer Research Quantum Mechanical (QM) Calculations Applied to ADMET Drug Prediction: A Review
Current Drug Metabolism Pharmaconutrition with Omega-3 Fatty Acids: Status Quo and Further Perspectives
Mini-Reviews in Medicinal Chemistry When “Chems” Meet Sex: A Rising Phenomenon Called “ChemSex”
Current Neuropharmacology D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function
Current Topics in Medicinal Chemistry The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Current Cancer Drug Targets DNA Vaccines: A Mini Review
Recent Patents on DNA & Gene Sequences Coumarins as Promising Scaffold for the Treatment of Age-related Diseases – An Overview of the Last Five Years
Current Topics in Medicinal Chemistry Anticancer, Antioxidant and Cytotoxic Potential of Thymol <i>in vitro</i> Brain Tumor Cell Model
Central Nervous System Agents in Medicinal Chemistry Derivation of Motor Neurons from three Clonal Human Embryonic Stem Cell Lines
Current Neurovascular Research Heart Failure in Chronic Myocarditis: A Role for microRNAs?
Current Genomics Transposons for Gene Therapy!
Current Gene Therapy Determination of 7,12-Dimethylbenz[a]Anthracene in Orally Treated Rats by High-Performance Liquid Chromatography and Transfer Stripping Voltammetry
Combinatorial Chemistry & High Throughput Screening Hydrogen Sulfide Regulates Vascular Inflammation and its Related Signaling Pathways
Current Signal Transduction Therapy Therapeutic Potential of Poncirin Against Numerous Human Health Complications: Medicinal Uses and Therapeutic Benefit of an Active Principle of Citrus Species
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthesis, Molecular Docking and In Vitro Antimicrobial Studies of Novel Pyrazole Analogues of Curcumin
Letters in Drug Design & Discovery A Bias in the Reading of the Genetic Code of <i>Escherichia coli</i> is a Characteristic for Genes that Specify Stress-induced MazF-mediated Proteins
Current Genomics Synthetic Peptides in the Diagnosis of Systemic Autoimmune Diseases
Current Protein & Peptide Science Molecular Docking Studies of Some Novel Antidepressant 5-Substituted Phenyl-3-(Thiophen-2-yl)-4, 5-Dihydro-1h-Pyrazole-1-Carboxamides Against Monoamine Oxidase Isoforms
Central Nervous System Agents in Medicinal Chemistry